SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-215074
Filing Date
2017-06-27
Accepted
2017-06-27 17:24:00
Documents
21
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 20-F d416340d20f.htm 20-F 1879252
2 EX-2.3 d416340dex23.htm EX-2.3 495102
3 EX-4.2 d416340dex42.htm EX-4.2 172372
4 EX-4.3 d416340dex43.htm EX-4.3 121294
5 EX-12.1 d416340dex121.htm EX-12.1 10336
6 EX-12.2 d416340dex122.htm EX-12.2 10325
7 EX-13.1 d416340dex131.htm EX-13.1 3751
8 EX-13.2 d416340dex132.htm EX-13.2 3750
9 GRAPHIC g416340im29.jpg GRAPHIC 60911
10 GRAPHIC g416340im30.jpg GRAPHIC 51515
11 GRAPHIC g416340im31.jpg GRAPHIC 51375
12 GRAPHIC g416340im33.jpg GRAPHIC 101106
13 GRAPHIC g416340im34.jpg GRAPHIC 117911
14 GRAPHIC g416340im35_1.jpg GRAPHIC 25671
15 GRAPHIC g416340im35_2.jpg GRAPHIC 38907
16 GRAPHIC g416340im36.jpg GRAPHIC 56252
17 GRAPHIC g416340im37.jpg GRAPHIC 53669
18 GRAPHIC g416340im38.jpg GRAPHIC 122258
19 GRAPHIC g416340im39n.jpg GRAPHIC 159107
20 GRAPHIC g416340im40.jpg GRAPHIC 71047
21 GRAPHIC g416340im42n.jpg GRAPHIC 85554
  Complete submission text file 0001193125-17-215074.txt   4069867
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 20-F | Act: 34 | File No.: 001-35776 | Film No.: 17933186
SIC: 2834 Pharmaceutical Preparations